Article 27 Apr 2022 OIG Finds Physician-Owned Medical Device Innovator Not A Suspect "POD" United States Healthcare
Article 20 Jan 2022 CMS Proposes Revised Definition Of Medicare Part D Drug "Negotiated Prices": Rule Could Increase Predictability For Pharmacies And Lower Medicare Enrollee Drug Cost-Sharing But Increase Premiums United States Healthcare
Article 16 Dec 2021 A New Year For Drug Pricing And Price Reporting? What's Happening Now And What's New For 2022 United States Healthcare
Article 29 Nov 2021 CMS Finalizes Repeal Of Medicare "Breakthrough" Device Coverage Rule, Pledges To Invite Further Industry Input United States Healthcare
Article 12 Feb 2021 President Biden's Buy American Executive Order Signals Possible Heightened False Claims Act Risk For Government Contractors United States Government
Article 25 Jan 2021 Medicare Expands Coverage Of "Breakthrough" Medical Devices And Codifies "Reasonable And Necessary" Standard United States Healthcare
Article 14 Jan 2021 Rutledge vs. PCMA: SCOTUS Greenlights State Regulation Of Pharmacy Benefit Manager Drug Reimbursement United States Employment
Article 28 Dec 2020 Midnight Changes To The Medicaid Drug Rebate Program Regulations United States Healthcare
Article 24 Dec 2020 HRSA Releases Final Rule Establishing Dispute Resolution Process For The 340B Program United States Healthcare
Article 11 Dec 2020 Cutting Out The "Middleman"? HHS Resurrects Anti-Rebate Rule For Medicare Part D United States Healthcare